Study to Evaluate the Effects of NMRA-323511 Among Healthy Elderly and Adults With Agitation Associated With Dementia Due to Alzheimer's Disease

NCT06546995 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

96

Enrollment

INDUSTRY

Sponsor class

Conditions

Alzheimer's Disease
Healthy Elderly

Interventions

DRUG: NMRA-323511
DRUG: Placebo

Sponsor

Neumora Therapeutics, Inc.